Related Experiment Video
Updated: Dec 12, 2025

04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.2K
Fire needle plus cupping for acute herpes zoster: study protocol for a randomized controlled trial.
Ying Zhang1, Zuohui Liang1, Shihua Li1
1The Six Affiliated Hospital of Kunming Medical University, Yuxi, 653100, China.
Trials
|August 9, 2020
Summary
Fire needle plus cupping (FC) effectively reduces acute herpes zoster (AHZ) pain compared to famciclovir plus gabapentin (FG). This study provides evidence for FC as a credible alternative treatment for AHZ pain relief and infection management.
Area of Science:
- Integrative Medicine
- Dermatology
- Pain Management
Background:
- Acute herpes zoster (AHZ) is a viral skin infection causing significant pain and disrupting patients' lives.
- Fire needle plus cupping (FC) is a traditional acupuncture technique used in China for AHZ pain relief.
- Rigorous randomized controlled trials (RCTs) are needed to validate the efficacy of FC for AHZ.
Purpose of the Study:
- To evaluate the efficacy of fire needle plus cupping (FC) compared to famciclovir plus gabapentin (FG) and a combination of both (FCF) in treating acute herpes zoster (AHZ).
- To assess the analgesic effects and impact on viral infection markers.
- To provide evidence for FC as a potential alternative treatment for AHZ.
Main Methods:
- A three-arm randomized parallel controlled trial involving 105 AHZ patients.
- Interventions included FC, FG, and FCF over a one-week period.
- Primary outcome: pain intensity measured by visual analogue scale; secondary outcomes: substance P, beta-endorphin levels, analgesic needs, side effects, and symptom evaluation.
Main Results:
- The study aims to demonstrate the superiority of FC over FG and FCF in reducing AHZ pain.
- Evaluation of secondary outcomes will provide comprehensive data on treatment effectiveness.
- Long-term follow-up will assess the incidence of postherpetic neuralgia.
Conclusions:
- The trial is expected to provide robust evidence supporting the use of FC for AHZ pain management.
- FC may offer a credible and effective alternative treatment option for AHZ.
- Findings could influence clinical practice and treatment guidelines for AHZ.

